Quantcast

Latest Gene therapy Stories

2013-10-11 23:01:25

World-class Research Fellows and Physicians to Present at the Harvard Club Oct.15 New York, NY and Stamford, CT (PRWEB) October 11, 2013 Alliance for Cancer Gene Therapy (ACGT), a not-for-profit dedicated exclusively to funding research for cancer treatments using cell and gene therapies, will host “Achieving Cancer Remission with Cell and Gene Therapies” on Tuesday, October 15 at the Harvard Club of New York City, 35 W. 44th Street. ACGT is renowned for devoting 100-percent of funds...

2013-10-11 12:01:09

A research team from Dana-Farber/Boston Children's Cancer and Blood Disorders Center and other institutions has discovered a new genetic target for potential therapy of sickle cell disease (SCD). The target, called an enhancer, controls a molecular switch in red blood cells called BCL11A that, in turn, regulates hemoglobin production. The researchers—led by Daniel Bauer, MD, PhD, and Stuart Orkin, MD, of Dana-Farber/Boston Children's—reported their findings today in Science. Prior...

2013-10-03 23:23:47

Reportbuyer.com just published a new market research report: Global Gene Therapy Market Analysis. London (PRWEB) October 03, 2013 Gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or abnormal and whose absence or abnormality is causing the disease. It has evolved as one of the most sought after research objectives for ‘difficult to cure’ diseases. The gene therapy market in spite of presenting few marketable products and being...

2013-10-01 23:27:22

American Gene Technologies uses cutting-edge gene therapy to attack virus. Rockville, Maryland (PRWEB) October 01, 2013 Almost 70 million people have been infected with the HIV virus since the beginning of the epidemic, and AIDS has claimed approximately 35 million lives, according to the World Health Organization. With nearly 36 million people around the globe living with HIV, American Gene Technologies International Inc. (AGT) is on a mission to use cutting-edge viral vectors and...

2013-09-23 23:22:43

The outstanding health-related program is set to air a segment on therapeutic outcomes which stem from new technological advances. Coral Springs, FL (PRWEB) September 23, 2013 The producers of Health Briefs TV are pleased to announce they are working on a segment which will examine the novel technologies being used to bring positive therapeutic outcomes. The topics will cover the use of e-readers to assist dyslexic students with reading disabilities to the top devices used in gene...

2013-09-05 11:26:35

Findings raise hope for new heart therapies Many people who survive a heart attack find themselves back in the hospital with a failing heart just years later. And the outcome often is unfavorable, owing to limited treatment options. But scientists at Temple University School of Medicine's Cardiovascular Research Center (CVRC) recently found hope in an unlikely source – stem cells in cortical, or compact, bone. In a new study, they show that when it comes to the regeneration of heart...

2013-09-03 10:13:25

The mitochondria are the powerhouses of the cell, converting energy into usable forms. When a child is born with a gene defect that results in dysfunctional mitochondria, the results can be devastating, causing physical and cognitive disability and often death. Using genome-wide sequencing along with personalized functional genomics, researchers led by those at Baylor College of Medicine have identified mutations in a gene called FBXL4 revealing it as a novel cause of primary mitochondrial...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related